CryoCath Technologies (Montreal, Quebec) received 510(k) regulatory clearance from the FDA in May for FrostByte, a clamp ablation device to be used in the treatment of cardiac arrhythmias. The company said it expected to receive CE mark approval shortly and launch the product this month.

Product Pipeline

Name: Relias Media
Price range: $

January 2, 2015

Reprints

Recognizing, Managing, and Reporting Pediatric Sexual Abuse and Assault
Eleventh Circuit Affirms Jury Verdict of $2.5 Million for Mesh Device Plaintiff Despite Close Call on Statute of Limitations
Indiana Appellate Court Allows Case to Proceed Against Doctor Accused of Improperly Accessing Patients’ Medical Records
Malpractice Insurance Rates Increasing After Stable Period
Clinical Decision Software Highly Effective in OR